CEL SCI Corp (CVM) income statement
CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
$1.38−0.47 (-25.41%)
Close on Nov 18, 2026Market cap $24.27MP/E –Yield –
CEL SCI Corp financial ratios
See a number that looks wrong?